Trials / Completed
CompletedNCT07297186
Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)
A Randomized, Blinded, Parallel Positive-controlled Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell) Conducted in Healthy Infants Aged Two Months.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,200 (actual)
- Sponsor
- Beijing Minhai Biotechnology Co., Ltd · Industry
- Sex
- All
- Age
- 60 Days – 89 Days
- Healthy volunteers
- Accepted
Summary
The study aimed to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine in infants aged two months (60\~89 days).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | sIPV | sIPVs were developed by Biominhai (Beijing Minhai Biotechnology Co. Ltd.) |
| BIOLOGICAL | wIPV | wIPVs were developed by Sanofi Pasteur |
Timeline
- Start date
- 2017-08-21
- Primary completion
- 2023-04-10
- Completion
- 2023-04-10
- First posted
- 2025-12-22
- Last updated
- 2025-12-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07297186. Inclusion in this directory is not an endorsement.